Interestingly, VU661013-treated ER+ breast cancer cells upregulated Mcl-1 protein levels, as shown by western analysis, although PLA confirmed that Mcl-1 interactions with Bim remained suppressed by VU661013. This evidence concerns the gene BCL2L11 and breast cancer.